Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9138775 | 0.85 | GAA (0.56) | GAA | |
| SCHEMBL5691079 | 0.83 | GAA (0.50) | GAA | |
| SCHEMBL27756376 | 0.82 | GAA (0.38) | GAA | |
| SCHEMBL27735718 | 0.81 | GAA (0.41) | GAA | |
| SCHEMBL130938 | 0.80 | — | — | |
| SCHEMBL1579162 | 0.78 | GAA (0.50) | GAA | |
| SCHEMBL130161 | 0.77 | GAA (0.31) | GAA | |
| SCHEMBL1103927 | 0.76 | GAA (0.48) | GAA | |
| SCHEMBL9466573 | 0.76 | GAA (0.48) | GAA | |
| SCHEMBL12060125 | 0.74 | GAA (0.46) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0982286-B1 | Diene compounds and process for preparing the same | TAKASAGO PERFUMERY CO LTD (JP) | 2005-02-23 | — | — | EP | claimed |
| US-8450319-B2 | Pyrrolopyridazinone compound | UBE INDUSTRIES, LTD. (JP) | 2013-05-28 | — | — | US | disclosed |
| EP-1982986-B1 | PYRROLOPYRIDAZINONE COMPOUND AS PDE4 INHIBITOR | UBE INDUSTRIES (JP) | 2012-03-07 | — | — | EP | disclosed |
| CN-101374844-A | Pyrrolopyridazinone compound | UBE INDUSTRIES (JP) | 2009-02-25 | — | — | CN | disclosed |
| US-20090036453-A1 | Pyrrolopyridazinone Compound | UBE INDUSTRIES, LTD. (JP) | 2009-02-05 | — | — | US | disclosed |
| EP-1982986-A1 | PYRROLOPYRIDAZINONE COMPOUND | Ube Industries, Ltd. (JP) | 2008-10-22 | — | — | EP | disclosed |
| EP-0982286-B1 | Diene compounds and process for preparing the same | TAKASAGO PERFUMERY CO LTD (JP) | 2005-02-23 | — | — | EP | disclosed |
| US-6323174-B1 | PERFUME COMPOSITION AT LEAST COMPRISING 4-METHYL-5-HEXEN-1-AL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-11-27 | — | — | US | disclosed |
| US-6239324-B1 | REACTING A 1,3-BUTADIENE WITH OLEFIN IN PRESENCE OF HYDROPHILIC SOLVENT AND RUTHENIUM COMPOUND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-05-29 | — | — | US | disclosed |
| EP-0982286-A2 | Diene compounds and process for preparing the same | Takasago International Corporation (JP) | 2000-03-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036453-A1 | Pyrrolopyridazinone Compound | CBR3, CBR1, CYC1 | GAA 4647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.